Načítá se...
Biodistribution and Dosimetry of Intraventricularly Administered (124)I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Radiation dose estimations are key for optimizing therapies. We studied the role of (124)I-omburtamab (8H9) given intraventricularly in assessing the distribution and radiation doses before (131)I-omburtamab therapy in patients with metastatic leptomeningeal disease and compared it with the estimate...
Uloženo v:
| Vydáno v: | J Nucl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society of Nuclear Medicine
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894373/ https://ncbi.nlm.nih.gov/pubmed/31405921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.219576 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|